Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Diabetes, Obesity & Metabolism|January 14, 2014
How many people inject insulin? UK estimates from 1991 to 2010S E Holden, E A M Gale, S Jenkins-Jones, et al.
Diabetes, Obesity & Metabolism|November 18, 2014
Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancerS E Holden, S Jenkins-Jones, C Ll Morgan, et al.
Diabetes, Obesity & Metabolism|April 12, 2014
Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational studyC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortalityC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 8, 2017
Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013S E Holden, S Jenkins-Jones, C Ll Morgan, et al.
Diabetes, Obesity & Metabolism|December 24, 2011
Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugsC Ll Morgan, S Jenkins-Jones, M Evans, et al.
The British Journal of Dermatology|November 3, 2017
Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativaJ R Ingram, S Jenkins-Jones, D W Knipe, et al.
Diabetes, Obesity & Metabolism|May 17, 2013
The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010S H Holden, A H Barnett, J R Peters, et al.
Diabetes, Obesity & Metabolism|July 22, 2014
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controlsC A Bannister, S E Holden, S Jenkins-Jones, et al.
The Bone & Joint Journal|January 7, 2018
The risk of cardiac failure following metal-on-metal hip arthroplastyS A Sabah, J C Moon, S Jenkins-Jones, et al.
Pageof 1